volume 7, issue 4, Pe35421 2012
DOI: 10.1371/journal.pone.0035421
View full text
Has correction Has correction 2012-08-09Has erratum
|
|
Share

Abstract: BackgroundSevere acute respiratory syndrome (SARS) emerged in China in 2002 and spread to other countries before brought under control. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was initiated. Evaluations of an inactivated whole virus vaccine in ferrets and nonhuman primates and a virus-like-particle vaccine in mice induced protection against infection but challenged animals exhibited an immunopathologic-type lung disease.DesignFour candidate vacc…

expand abstract
editorial notices